Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Prokidney (PROK) Equity Average (2022 - 2025)

Prokidney (PROK) has disclosed Equity Average for 4 consecutive years, with -$1.0 billion as the latest value for Q3 2025.

  • On a quarterly basis, Equity Average fell 2.99% to -$1.0 billion in Q3 2025 year-over-year; TTM through Sep 2025 was -$1.0 billion, a 2.99% decrease, with the full-year FY2024 number at -$1.0 billion, up 4.62% from a year prior.
  • Equity Average was -$1.0 billion for Q3 2025 at Prokidney, roughly flat from -$1.0 billion in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $13.4 million in Q2 2022 to a low of -$1.5 billion in Q2 2023.
  • A 4-year average of -$988.9 million and a median of -$1.0 billion in 2024 define the central range for Equity Average.
  • Peak YoY movement for Equity Average: crashed 11048.79% in 2023, then grew 29.25% in 2024.
  • Prokidney's Equity Average stood at -$1.1 billion in 2022, then fell by 0.14% to -$1.1 billion in 2023, then grew by 10.08% to -$987.3 million in 2024, then fell by 1.82% to -$1.0 billion in 2025.
  • Per Business Quant, the three most recent readings for PROK's Equity Average are -$1.0 billion (Q3 2025), -$1.0 billion (Q2 2025), and -$996.8 million (Q1 2025).